Morningstar, Inc.
MORN
$172.21
-2.39%
Morningstar, Inc. is a leading global provider of independent investment research, data, and analytics, operating within the Financial - Data & Stock Exchanges industry. The company is a distinct market leader known for its trusted, independent insights delivered to financial advisers, asset managers, and investors through platforms like Morningstar Direct, PitchBook, and Morningstar Credit. The current investor narrative is dominated by a significant stock price decline and a debate over whether this represents a value opportunity or reflects deeper challenges, as the company navigates a period of underperformance relative to the broader market while continuing to execute its multi-platform strategy.…
MORN
Morningstar, Inc.
$172.21
Investment Opinion: Should I buy MORN Today?
Rating: Hold. The core thesis is that Morningstar is a fundamentally sound company caught in a severe sentiment and technical downdraft, making it too risky to buy the dip but too cheap to sell outright.
Supporting evidence includes a forward P/E of 12.95x, which is reasonable for a company with a 30.6% ROE and 17.95% net margin. Revenue growth is steady at 8.5% YoY, and profitability has improved sequentially through 2025. The company generates strong free cash flow ($442.6M TTM). However, these positives are counterbalanced by a leveraged balance sheet (D/E of 1.15), illiquidity (current ratio 0.985), and catastrophic relative underperformance (-67.5% vs. SPY).
The thesis would upgrade to Buy if the stock stabilizes above the $149 support on strong volume and the next quarterly report shows gross margins holding above 61% with revenue growth accelerating. It would downgrade to Sell if the debt-to-equity ratio worsens above 1.2, revenue growth decelerates below 5%, or the $149 support breaks decisively. Valuation verdict: The stock appears fairly valued to slightly undervalued on forward earnings, but the significant balance sheet and sentiment risks justify a wide margin of safety, resulting in a Hold recommendation.
Sign up to view all
MORN 12-Month Price Forecast
Morningstar is a battleground stock where solid fundamentals are losing to terrible technicals and balance sheet concerns. The neutral stance reflects the high probability (55%) of a base case where the stock muddles through with muted returns. The stance would upgrade to bullish on confirmation of a successful technical base formation above $149 coupled with a quarterly report showing debt stabilization. It would turn bearish on a breakdown below $149 with simultaneous deterioration in gross margins, signaling the value trap narrative is correct. The limited analyst coverage adds an element of unpredictability to price discovery.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Morningstar, Inc.'s 12-month outlook, with a consensus price target around $223.87 and implied upside of +30.0% versus the current price.
Average Target
$223.87
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$138 - $224
Analyst target range
Analyst coverage for Morningstar is limited, with only 2 analysts providing estimates, indicating this is a small/mid-cap name with less institutional scrutiny which can lead to higher volatility and less efficient price discovery. The consensus sentiment, based on the limited data, appears neutral to cautiously optimistic, with estimated revenue for the next period at $3.04 billion and estimated EPS averaging $17.01. The target price range implied by EPS estimates is wide, with a low of $16.47 and a high of $17.42, reflecting the uncertainty inherent in limited coverage. The high target likely assumes successful execution on growth initiatives and margin stability, while the low target may factor in continued competitive pressures or macroeconomic headwinds impacting the financial services sector. Recent institutional rating actions, such as BMO Capital maintaining an 'Outperform' rating as recently as February 2026 and UBS maintaining a 'Buy' in October 2025, suggest some maintained bullish conviction among the few covering firms despite the stock's severe price decline.
Bulls vs Bears: MORN Investment Factors
The evidence presents a classic value vs. value trap dilemma. The bear case currently holds stronger evidence, as the stock's severe underperformance, accelerating short-term losses, and leveraged balance sheet reflect tangible, ongoing distress. However, the bull case is supported by compelling fundamentals: strong profitability, cash flow, and a forward P/E that prices in a deep discount. The single most important tension is whether the company's solid underlying financial performance (8.5% revenue growth, 18% net margin) can overcome the market's overwhelming technical and sentiment-driven selling pressure. The resolution hinges on whether the next earnings report confirms operational stability or reveals cracks that justify the sell-off.
Bullish
- Strong Profitability & Margin Expansion: Morningstar's Q4 2025 net margin reached 17.95%, up from 13.5% in Q1 2025, demonstrating significant operational leverage. The company also generated robust free cash flow of $442.6 million on a TTM basis, providing financial flexibility.
- Attractive Forward Valuation: The stock trades at a forward P/E of 12.95x, a significant discount to its trailing P/E of 24.33x, implying the market expects strong earnings growth. This multiple is low for a company with a 30.6% ROE and a 61% gross margin.
- Deeply Oversold Technicals: The stock is down 37.95% over the past year and trades near its 52-week low of $149.08, approximately 53% of the distance from its high. This extreme sell-off, coupled with a beta of 1.11, suggests a potential for a sharp rebound on any positive catalyst.
- Steady Revenue Growth: Q4 2025 revenue grew 8.48% YoY to $641.1 million, with sequential growth throughout the year. The core Licensed-Based segment, contributing $437.8 million, shows the stability of the subscription model.
Bearish
- Severe Price & Relative Underperformance: MORN has underperformed the SPY by 67.47% over the past year, indicating deep-seated investor concerns beyond general market weakness. The stock is down 22.53% in the last 3 months, showing accelerating selling pressure.
- Leveraged & Illiquid Balance Sheet: The company's debt-to-equity ratio is elevated at 1.15, and its current ratio is below 1 at 0.985. This indicates potential liquidity constraints and financial risk if operating cash flows were to weaken.
- Limited Analyst Coverage & Uncertainty: Only 2 analysts provide estimates, leading to less efficient price discovery and higher volatility. The wide implied EPS target range ($16.47 to $17.42) reflects significant uncertainty about future performance.
- High Valuation on Trailing Metrics: Despite the recent crash, the trailing P/E of 24.33x remains above the lower end of its recent historical range (19.12x-50.93x). The PEG ratio of 7.25 is extremely high, signaling growth expectations are already priced in.
MORN Technical Analysis
The prevailing price trend for Morningstar is a pronounced and sustained downtrend, with the stock down 37.95% over the past year. The current price of $167.97 sits near the lower end of its 52-week range, trading at approximately 53% of the distance between its 52-week low of $149.08 and high of $316.71. This positioning near the lows suggests the stock is deeply oversold, presenting a potential value opportunity, though it also risks being a 'falling knife' if the fundamental outlook continues to deteriorate. Recent short-term momentum shows continued weakness, with the stock down 6.40% over the past month and 22.53% over the past three months, indicating that selling pressure has accelerated relative to the longer-term downtrend. This divergence, where short-term losses are intensifying, signals persistent bearish sentiment and a lack of near-term catalysts for recovery. Key technical levels are clearly defined, with immediate support at the 52-week low of $149.08 and resistance far above at the 52-week high of $316.71. A breakdown below the $149 support could trigger another leg down, while a sustained move above it might indicate a base is forming. The stock's beta of 1.112 indicates it is approximately 11% more volatile than the broader market (SPY), which is notable given its 67.47% underperformance relative to the SPY over the past year, highlighting its heightened idiosyncratic risk.
Beta
1.11
1.11x market volatility
Max Drawdown
-50.9%
Largest decline past year
52-Week Range
$149-$317
Price range past year
Annual Return
-39.1%
Cumulative gain past year
| Period | MORN Return | S&P 500 |
|---|---|---|
| 1m | -6.0% | +4.9% |
| 3m | -21.7% | +0.6% |
| 6m | -18.3% | +5.1% |
| 1y | -39.1% | +28.8% |
| ytd | -18.2% | +1.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MORN Fundamental Analysis
Morningstar's revenue trajectory shows steady growth, with Q4 2025 revenue reaching $641.1 million, representing an 8.48% year-over-year increase. The multi-quarter trend reveals consistent sequential growth from $581.9 million in Q1 to $641.1 million in Q4 of 2025, indicating a stable, mid-single-digit growth profile. Segment data shows the Licensed-Based segment is the primary driver, contributing $437.8 million, while the Asset-Based and Transaction-Based segments contributed $90.2 million and $113.1 million respectively, suggesting the core subscription model remains robust. The company is profitable, reporting Q4 2025 net income of $115.1 million and a net margin of 17.95%. Gross margin for the quarter was a healthy 61.13%, and the operating margin was 24.89%. Profitability has improved sequentially through 2025, with net income growing from $78.5 million in Q1 to $115.1 million in Q4, demonstrating effective margin expansion and operational leverage. The balance sheet and cash flow position is mixed; the company generated strong free cash flow of $442.6 million on a TTM basis and an operating cash flow of $204 million in Q4 alone. However, the debt-to-equity ratio of 1.15 indicates a leveraged balance sheet, and the current ratio of 0.985 suggests potential liquidity constraints in covering short-term obligations with current assets.
Quarterly Revenue
$641100000.0B
2025-12
Revenue YoY Growth
+0.08%
YoY Comparison
Gross Margin
+0.61%
Latest Quarter
Free Cash Flow
$442600000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MORN Overvalued?
Given Morningstar's positive net income of $115.1 million, the primary valuation metric selected is the Price-to-Earnings (P/E) ratio. The stock trades at a trailing P/E of 24.33x and a forward P/E of 12.95x, based on estimated EPS. The significant gap between trailing and forward multiples implies the market expects a substantial earnings recovery or growth acceleration in the coming year. Compared to sector averages, Morningstar's trailing P/E of 24.33x and Price-to-Sales (P/S) ratio of 3.72x are not directly comparable without a provided industry average, but its EV/EBITDA of 13.77x suggests a moderate valuation for a financial data and analytics firm. The premium or discount justification hinges on its growth profile and strong cash flow generation relative to its leveraged balance sheet. Historically, the stock's current trailing P/E of 24.33x is above its own recent historical range observed in the data, where it traded between 19.12x and 50.93x over the past several quarters. Trading near the middle of this band suggests the market is pricing in a recovery from recent lows but remains cautious, not yet assigning the premium multiples seen during more optimistic periods in 2024 and early 2025.
PE
24.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -284x~697x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on Morningstar's balance sheet and growth sustainability. The debt-to-equity ratio of 1.15 indicates significant leverage, which could pressure earnings if interest rates remain elevated. More immediately, the current ratio of 0.985 signals potential liquidity strain, as current assets may not fully cover short-term liabilities. While revenue grew 8.5% YoY, this mid-single-digit pace may be insufficient to justify a forward P/E of 12.95x if growth decelerates further, leading to multiple compression.
Market & Competitive Risks are pronounced given the stock's valuation and sector dynamics. The trailing P/E of 24.33x, while down from highs, still implies a premium that is vulnerable if investor sentiment sours further on financial data providers. The stock's beta of 1.112 confirms it is more volatile than the market, amplifying downside during sector rotations. A key external threat is competition from larger, better-capitalized rivals (e.g., Bloomberg, Refinitiv) potentially pressuring pricing and market share for Morningstar's core platforms like Morningstar Direct and PitchBook.
Worst-Case Scenario involves a continuation of the current downtrend triggered by a disappointing earnings report that shows margin compression or growth stalling. This could lead analysts to cut estimates, invalidating the forward P/E thesis. The specific chain would be: Q1 2026 miss -> analyst downgrades -> breach of $149.08 support -> forced selling by leveraged or technical investors. Realistic downside could see the stock re-test its 52-week low of $149.08, representing an 11% decline from the current $167.97. A more severe scenario, aligning with the stock's max drawdown of -50.94%, could see it fall towards $155, a loss of approximately 8%.
FAQ
The key risks are, in order of severity: 1) Financial Risk: The leveraged balance sheet (debt-to-equity of 1.15) and weak liquidity (current ratio of 0.985) could strain operations if cash flow weakens. 2) Sentiment & Technical Risk: The stock is in a powerful downtrend, down 38% in a year, and a break below $149 support could trigger another leg down. 3) Competitive & Market Risk: As a smaller player in financial data, it faces intense competition from larger rivals, which could pressure pricing and growth. 4) Coverage & Liquidity Risk: With only 2 analysts covering it, the stock suffers from inefficient price discovery and can be prone to sharp moves on low volume.
The 12-month forecast is bifurcated, with a base case target range of $170-$210 (55% probability), a bull case of $240-$280 (25%), and a bear case of $140-$160 (20%). The most likely scenario is the base case, where the stock trades sideways as steady ~8% revenue growth and strong margins are offset by balance sheet concerns and poor technicals. This forecast assumes the company meets the analyst consensus EPS estimate of $17.01. The key variable is whether investor sentiment stabilizes; without it, even solid fundamentals may not lift the price meaningfully from current levels.
MORN sends mixed valuation signals. On a trailing basis, its P/E of 24.33x appears full, even after the crash, sitting above the lower end of its recent historical range. However, the forward P/E of 12.95x suggests the market expects a significant earnings rebound and prices the stock at a discount. Compared to its own fundamentals, the stock seems fairly valued to slightly undervalued on forward earnings, given its high ROE (30.6%) and margins. The market is paying a fair price for expected growth but is demanding a discount due to balance sheet and sentiment risks. The valuation implies the market expects mid-single-digit growth to continue but remains wary of financial or competitive shocks.
MORN presents a high-risk, potentially high-reward opportunity that is not suitable for all investors. For a risk-tolerant, contrarian investor, the current price near 52-week lows and a forward P/E of 12.95x could represent a good entry point, assuming the company's strong profitability (18% net margin) and cash flow ($442M FCF) prevail. However, the significant risks—including a leveraged balance sheet (D/E 1.15), illiquidity (current ratio 0.985), and severe technical damage (-38% over 1 year)—make it a speculative buy. It is a good buy only for those who have done deep due diligence, believe the fundamentals will overcome sentiment, and can accept further downside towards $149.
MORN is unsuitable for short-term trading due to its high volatility (beta 1.11), low liquidity, and entrenched downtrend, which could lead to rapid losses. It is primarily a candidate for long-term investment (3-5 years) for investors betting on a fundamental turnaround and multiple expansion. The company's strong brand, recurring revenue model, and cash generation support a long-term hold thesis. However, given the significant risks, any position should be sized appropriately as part of a diversified portfolio. A minimum holding period of 2-3 years is suggested to allow time for the operational story to overcome the current technical and sentiment overhang.